Identifying youth nonadherence in clinical settings: Data-based recommendations for children and adolescents with inflammatory bowel disease

Inflammatory Bowel Diseases

Volumn 18, Issue 7, 2012, Pages 1254-1259

  Greenley, Rachel Neff ^a   Kunz, Jennifer Hauser ^a   Biank, Vincent ^b   Martinez, Alfonso ^b   Miranda, Adrian ^b   Noe, Joshua ^b   Telega, Grzegorz ^b   Tipnis, Neelesh Ajit ^b   Werlin, Steven ^b   Stephens, Michael C ^b  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Compliance issues in IBD; Pediatrics; Psychosocial aspects of IBD

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; ENTERITIS; FEMALE; HUMAN; JUVENILE; MAJOR CLINICAL STUDY; MALE; MATERNAL CARE; MEDICAL ADHERENCE MEASURE; MEDICATION EVENTS MONITORING SYSTEM; ONLINE SYSTEM; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; QUESTIONNAIRE; SCHOOL CHILD; SELF REPORT; SENSITIVITY AND SPECIFICITY; VALIDITY;

6-MERCAPTOPURINE; ADOLESCENT; CAREGIVERS; CHILD; DATABASES, FACTUAL; DRUG MONITORING; FAMILY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; MEDICATION ADHERENCE; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; QUESTIONNAIRES; SELF REPORT;

EID: 84858420657     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21859     Document Type: Article

References (20)

1. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429. (Pubitemid 350181588)
2. Markowitz J, Rosa J, Grancher K, et al. Long term 6-mercaptopurine treatment in adolescents with Crohn's disease. Gastroenterology. 1990;99:1347-1351. (Pubitemid 20381869)
3. Riello L, Talbotec C, Garnier-Lengline H, et al. Tolerance and efficacy of azathioprine in pediatric Crohn's disease. Inflamm Bowel Dis. 2011 [Epub ahead of print, doi: 10.1002/ibd.21612].
4. Hommel KA, Davis CM, Baldassano RN. Medication adherence and quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol. 2008;33:867-874.
5. Hommel KA, Davis CM, Baldassano RN. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:589-593.
6. Ingerski LM, Baldassano RN, Denson LA, et al. Barriers to oral medication adherence for adolescents with inflammatory bowel disease. J Pediatr Psychol. 2010;35:683-691.
7. Mackner LM, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11: 1006-1012. (Pubitemid 41580015)
8. Quittner AL, Modi AC, Lemaneck KL, et al. Evidence-based assessment of adherence to medical treatments in pediatric psychology. J Pediatr Psychol. 2008;33:916-936.
9. Oliva-Hemker MM, Abadom V, Cuffari C, et al. Nonadherence with thiopurine immuodulator and mesalamnie medications in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2007;44:180-184. (Pubitemid 46175069)
10. Greenley RN, Josie KL, Drotar D. Perceived involvement in condition management among inner-city youth with asthma and their primary caregivers. J Asthma. 2006;43:687-693. (Pubitemid 44722126)
11. Wysocki T, Gavin L. Paternal involvement in the management of pediatric chronic diseases: associations with adherence, quality of life, and health status. J Pediatr Psychol. 2006;31:501-511.
12. Zelikovsky N, Schast AP. Eliciting accurate reports of adherence in a clinical interview: development of the medical adherence measure. Pediatr Nurs. 2008;34:141-146.
13. Hanauer S, Schwartz J, Robinson M, et al. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. Am J Gastroenterol. 1993;88:1188-1197. (Pubitemid 23219711)
14. Greenley RN, Doughty A, Stephens M, et al. Brief report: development of the inflammatory bowel disease family responsibility questionnaire. J Pediatr Psychol. 2010;35:183-187.
15. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530. (Pubitemid 40847288)
16. Ventura J, Liberman RP, Green MF, et al. Training and quality assurance with the structured clinical interview for DSM-IV (SCID-I/P). Psych Res. 1998;79:163-173. (Pubitemid 28308489)
17. Schurman JV, Cushing CC, Carpenter E, et al. Volitional and accidental nonadherence to pediatric inflammatory bowel disease treatment plans: initial investigation of associations with quality of life and disease activity. J Pediatr Psychol. 2011;36:116-125.
18. Hommel KA, Baldassano RN. Brief report: barriers to treatment adherence in pediatric inflammatory bowel disease. J Pediatr Psychol. 2010;35:1005-1010.
19. Greenley RN, Stephens M, Doughty A, et al. Barriers to adherence among adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:36-41.
20. Chen H, Cohen P, Chen S. How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Commun Stat Simul Comput. 2010;39:860-864.